Why Symptoms from Different Systems Appear Together

Valsa Madhava, MD

Sep 26

4 min read

Updated: Oct 6

Week 2 of the Symptom Patterns Series

Why symptoms from different parts of the body may appear together.

What You Notice

During benzodiazepine withdrawal, some people experience symptoms that seem to involve completely different parts of the body. A racing heart, digestive changes, and dizziness may occur during the same period. Muscle tension may appear alongside poor sleep and internal restlessness.

A natural question follows: are these separate problems that happen to be occurring at the same time, or might they be connected?

Week 1 introduced the idea that symptoms from different systems can appear together in recognizable patterns. This article considers why a cross-system symptom picture is biologically plausible.

Regulatory Systems Are Distinct but Interconnected

The body does not manage its functions in separate, sealed-off compartments. The systems involved in arousal, excitability, heart rate and digestion, movement, sleep, and visceral regulation are distinct, but they are not independent. They are linked and continuously interact.

Because these systems are interconnected, a change affecting one function may also show up alongside changes in other functions. This provides a straightforward reason why symptoms involving different parts of the body may appear during the same period.

Withdrawal-Related Adaptation Is Not Confined to One Function

Benzodiazepines act broadly across the nervous system, not on only one small area or one function. With ongoing exposure, the nervous system may adapt to the medication.

When the medication is reduced or stopped, those adaptations may be reflected across more than one regulatory system during the same period.

This is a biologically plausible explanation for a cross-system symptom picture, not a mechanism established for particular symptom patterns in humans. Much of the detailed mechanistic evidence comes from preclinical research and cannot determine what produces an individual person’s symptoms.

What Appearing Together Does — and Does Not — Mean

When a racing heart, digestive changes, and dizziness occur during the same period, the current symptom picture reflects several regulatory functions. The same is true when muscle tension, poor sleep, and internal restlessness appear together.

Their co-occurrence does not establish that:

every symptom has the same cause;
every associated system has changed in the same way;
all the symptoms rise and fall together;
one underlying process explains the entire picture.

A symptom pattern describes recognizable organization within the current clinical picture. It does not establish a single mechanism.

What the Exploratory Analysis Adds

Published withdrawal literature describes a broad and varied set of symptoms involving multiple body and nervous-system functions. However, these symptoms have not been organized into a widely accepted classification.

An exploratory cross-sectional analysis examined whether symptom profiles contained organization beyond differences in overall symptom burden. In reports from 39 people experiencing benzodiazepine withdrawal, relationships among symptom severities across people showed additional non-random structure.

This finding provides preliminary evidence of structured symptom relationships within this cohort. It does not establish fixed subtypes, prove a mechanism, or show that symptoms within a pattern rise and fall together within an individual over time.

Connection to the Five-Axis Stress Biology Framework™

Within the Five-Axis Stress Biology Framework™ educational model, symptoms are organized across five broad areas: CRH/Adrenergic Stress (Axis 1), Excitatory–Neuroinflammatory (Axis 2), Autonomic (Axis 3), Basal Ganglia–Cerebellar Motor (Axis 4), and Neuroimmune/Visceral Regulation (Axis 5).

The framework describes broad regulatory systems that may be linked to symptoms. A pattern describes how symptoms associated with several of those systems appear within a person’s current clinical picture.

Sometimes symptoms linked to one system are especially prominent, with symptoms linked to other systems appearing alongside them. In other cases, the symptom picture is more broadly distributed.

Why This Distinction Matters

Recognizing a cross-system pattern may make a complicated experience easier to describe. It can shift the question from:

“Why do I have so many unrelated problems?”

to:

“Which functions appear to be involved in my current symptom picture?”

This does not make the pattern a diagnosis or explain the cause of every symptom. The proposed patterns are provisional and overlapping, and they may change over time.

Some people reduce or stop benzodiazepines with few or manageable symptoms and never develop a severe multisystem presentation. New or changing symptoms always deserve individual medical evaluation.

The next articles will examine specific provisional patterns, beginning with the threat and arousal pattern.

Figure 2. Interconnected regulatory systems and a cross-system symptom picture

The five broad regulatory systems are interconnected rather than isolated. The center shows an example of symptoms involving several functions appearing within the same clinical picture. The figure is illustrative: it does not assign each symptom to only one system, establish that all five systems are involved in every person, or show that one system causes another. The combination of symptoms and systems represented may differ between people and may change within the same person over time.

About the Evidence

The patterns in this series are provisional educational descriptions informed by published withdrawal literature, the author’s own exploratory cross-sectional analysis of 39 people, the Five-Axis Stress Biology Framework™ educational model, and clinical observation.

They are not diagnoses or fixed subtypes and do not establish a mechanism. The available evidence does not show that symptoms within a pattern rise and fall together as a unit over time. Severe multisystem withdrawal is not universal, and these patterns do not replace individual medical evaluation.

Selected Scientific References

Allison, C., & Pratt, J. A. (2003). Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence. Pharmacology & Therapeutics, 98(2), 171–195. https://doi.org/10.1016/S0163-7258(03)00029-9
Ashton, H. (1991). Protracted withdrawal syndromes from benzodiazepines. Journal of Substance Abuse Treatment, 8(1–2), 19–28. https://doi.org/10.1016/0740-5472(91)90023-4
Pétursson, H. (1994). The benzodiazepine withdrawal syndrome. Addiction, 89(11), 1455–1459. https://doi.org/10.1111/j.1360-0443.1994.tb03743.x
Shade, K. N., et al. (2025). Long-term neurological consequences following benzodiazepine exposure: A scoping review. PLOS ONE, 20(8), e0330277. https://doi.org/10.1371/journal.pone.0330277

The mechanistic references are cited to support biological plausibility—not as evidence that a specific symptom-pattern mechanism has been demonstrated in human benzodiazepine withdrawal. The Series 4 organizational analysis is the author’s own exploratory analysis, is in preparation for publication, and has not yet been externally replicated.

For educational purposes only. Not a substitute for individual medical evaluation.